Century-Old Wild Ginseng Cloned in Giant Bioreactors Keeps Its Chemistry Intact

A 150-year-old wild mountain ginseng plant, one of the most prized and rarest specimens in traditional East Asian medicine, has been coaxed into producing laboratory-grown roots that faithfully preserve its genetic identity while developing a distinctive chemical signature of their own. The achievement, reported in BMC Plant Biology by a team of Korean researchers led by Han-Sol Lee and So-Young Park of Chungbuk National University, demonstrates that the precious chemistry locked inside a century-and-a-half of slow growth in mountain soil can, in principle, be manufactured at industrial scale without ever uprooting another wild plant.

Wild mountain ginseng, Panax ginseng Meyer, occupies a near-mythical status across Korea, China, and Japan, where it has been harvested for centuries as a medicinal herb and health food. Its value stems from ginsenosides, a family of triterpene saponins that constitute the plant’s primary pharmacological constituents. These compounds are conventionally divided into three structural groups: the protopanaxadiol type, which includes well-studied molecules such as Rb1, Rb2, Rb3, Rd, Rg3, and Rh2; the protopanaxatriol type, encompassing Re, Rf, Rg1, Rg2, and Rh1; and the oleanolic acid type, represented by Ro and related saponins. Decades of research have attributed a remarkable spectrum of biological activities to ginsenosides, including immune enhancement, antioxidant and antibacterial effects, antidiabetic and anti-inflammatory actions, anti-aging properties, and cardioprotective and neuroprotective benefits.

The problem, of course, is supply. A wild mountain ginseng root of this age is an extraordinarily rare resource, and demand for authentic, high-quality material far exceeds what nature can provide. The research team’s strategy was to sidestep the bottleneck entirely by generating adventitious roots, roots that arise from somatic tissue rather than from seed germination, from the 150-year-old specimen, designated 150y-Mg. These cultured roots were then scaled up in 1000-liter industrial bioreactors, where they grew in Murashige and Skoog medium supplemented with 5 percent sucrose by weight and 5 milligrams per liter of indole-3-butyric acid, a synthetic auxin that promotes root growth and ginsenoside accumulation.

The central question was whether the cultured roots could genuinely be considered the same plant. To answer it, the researchers turned to SNP genotyping, a technique that reads single-nucleotide variations scattered across the genome and produces a molecular fingerprint unique to each individual. Using a panel of 192 SNP markers, they compared the original mountain ginseng with two independently analyzed adventitious root samples. The result was unambiguous: 100 percent genotype concordance across the entire panel. Of the 192 loci, 184 were homozygous, meaning both copies of the gene carried the same variant, five were heterozygous, and three produced null calls that could not be scored. Calculated across the 189 callable non-null loci, the genetic fixation rate stood at 97.4 percent, a figure that reflects the high homozygosity typical of a long-lived, likely self-purging lineage rather than any discrepancy between the parent plant and its cultured offspring.

With genetic identity confirmed, the team shifted to the metabolome, the complete inventory of small molecules that defines what a plant actually produces. Liquid chromatography coupled with mass spectrometry, or LC–MS, revealed clear chemical differences among the analyzed materials. Within the sample set examined, malonyl ginsenoside Rb2/Rb3 was detected in the original 150-year-old mountain ginseng but not in cultivated Panax ginseng, whereas ginsenosides XVII and F2 appeared in the bioreactor-grown adventitious roots but were absent from cultivated ginseng under the same analytical conditions. The authors are careful to frame these observations as comparison-specific metabolite features rather than validated authentication markers, a distinction that matters for any future attempt to certify the origin of ginseng products in the marketplace.

That caution is scientifically warranted. A single comparison between one wild specimen and one cultivated reference cannot establish whether a particular metabolite is truly characteristic of age, habitat, or lineage. Environmental conditions, developmental stage, and analytical parameters can all shift the metabolic profile of ginseng tissue. What the LC–MS data do provide is a shortlist of candidate compounds, malonyl ginsenoside Rb2/Rb3, ginsenoside XVII, and ginsenoside F2, that now deserve systematic validation across broader and independent ginseng cohorts before they could ever serve as reliable markers of wild mountain provenance.

Complementing the LC–MS work, high-performance liquid chromatography, or HPLC, quantified the ginsenoside content of the adventitious roots and revealed distinct quantitative patterns that set them apart from conventional material. The relative proportions of individual saponins matter enormously for pharmacological activity, since different ginsenosides act on different molecular targets in the human body. A culture line that skews toward particular saponin classes could, with further optimization, become a standardized source of specific bioactive molecules, something that wild-harvested roots, with their inherent variability, can never guarantee.

The biomedical potential of the bioreactor-grown roots was explored through preliminary in vitro assays. These experiments provided early evidence of two activities of considerable commercial and clinical interest: anti-inflammatory effects and the ability to stimulate the proliferation of dermal papilla cells, the specialized fibroblasts at the base of hair follicles that regulate hair growth. The dermal papilla finding in particular hints at possible applications in cosmetics and hair-loss research, an area where ginseng-derived compounds have long attracted attention. The authors emphasize, however, that these are preliminary results, and the path from a cell-culture assay to a validated therapeutic or cosmetic ingredient involves extensive further testing.

What makes this study notable is not any single result but the complete pipeline it demonstrates. A rare, irreplaceable botanical resource was captured genetically, propagated indefinitely in sterile culture, scaled to industrial volumes, verified as a true genetic match, and profiled chemically and functionally, all without the plant ever leaving the laboratory. The 1000-liter bioreactor scale is the crucial detail here: it transforms what would otherwise be a botanical curiosity into a feasible production platform. Adventitious root culture of ginseng has been explored before, but anchoring the technology to a documented 150-year-old wild genotype, with SNP-level traceability, raises the standard for authenticity in an industry plagued by adulteration and mislabeling.

The researchers are candid about the limits of the current work. The metabolite features they observed are candidates, not conclusions, and the in vitro activities require confirmation in more rigorous models. Yet the foundation they have laid, complete genetic concordance, a reproducible culture system, and a defined chemical baseline, gives the field exactly what it needs to move forward: a stable reference material against which future wild and cultivated ginseng samples can be compared. If subsequent studies validate the candidate markers across independent cohorts, the combination of SNP fingerprinting and LC–MS profiling could become a powerful authentication toolkit. And if the anti-inflammatory and dermal papilla activities hold up, the roots of a plant that took 150 years to grow in the mountains may one day be produced by the ton, its ancient chemistry preserved in stainless steel tanks rather than in vanishing forest soil.

Subject of Research: Metabolomic profiling and bioreactor production of adventitious roots from a 150-year-old wild mountain ginseng

Article Title: Metabolomic profiling and biomedical potential of adventitious roots derived from a 150-year-old mountain ginseng

Article References: Lee, H.-S., Han, J.-E., Kwon, A.-R., Son, E.-J., Park, H., Kim, M.-O., Kim, Y. J., Lee, K. Y., Yang, T.-J., Murthy, H. N., Paek, K.-Y., & Park, S.-Y. (2026). Metabolomic profiling and biomedical potential of adventitious roots derived from a 150-year-old mountain ginseng. BMC Plant Biology. https://doi.org/10.1186/s12870-026-10136-1

Image Credits: AI Generated

DOI: 10.1186/s12870-026-10136-1

Keywords: Panax ginseng, mountain ginseng, ginsenosides, adventitious roots, metabolomics, LC-MS, SNP genotyping, plant biotechnology, bioreactor, anti-inflammatory, dermal papilla cells, BMC Plant Biology